Skip Nav Destination
Issues
1 May 2001
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
The Cooperative Group Bulletin Board
Minireview
Review
Advances in Brief
Clinical Trials
Lethal Outcome of a Patient with a Complete Dihydropyrimidine Dehydrogenase (DPD) Deficiency after Administration of 5-Fluorouracil: Frequency of the Common IVS14+1G>A Mutation Causing DPD Deficiency1
André B. P. van Kuilenburg; Erik W. Muller; Janet Haasjes; Rutger Meinsma; Lida Zoetekouw; Hans R. Waterham; Frank Baas; Dick J. Richel; Albert H. van Gennip
Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment1: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001.
Uwe Wagner; Siegmund Köhler; Silke Reinartz; Patrick Giffels; Jens Huober; Kirsten Renke; Harald Schlebusch; Hans-Jürgen Biersack; Volker Möbus; Rolf Kreienberg; Thomas Bauknecht; Dieter Krebs; Diethelm Wallwiener
Alteration of Interleukin 2 (IL-2) Pharmacokinetics and Function by IL-2 Antibodies Induced after Treatment of Colorectal Carcinoma Patients with a Combination of Monoclonal Antibody 17-1A, Granulocyte Macrophage Colony-Stimulating Factor, and IL-21
Anna-Lena Hjelm Skog; Meenu Wadhwa; Moustapha Hassan; Baback Gharizadeh; Chris Bird; Peter Ragnhammar; Robin Thorpe; Håkan Mellstedt
The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma1
Margaret von Mehren; Philip Arlen; James Gulley; André Rogatko; Harry S. Cooper; Neal J. Meropol; R. Katharine Alpaugh; Monica Davey; Susan McLaughlin; Mary T. Beard; Kwong Y. Tsang; Jeffrey Schlom; Louis M. Weiner
Reduction of Paclitaxel-induced Peripheral Neuropathy with Glutamine1
Linda Vahdat; Kyriakos Papadopoulos; Dale Lange; Shelby Leuin; Elizabeth Kaufman; Diana Donovan; Deborah Frederick; Emilia Bagiella; Amy Tiersten; Gwen Nichols; Thomas Garrett; David Savage; Karen Antman; Charles S. Hesdorffer; Casilda Balmaceda
Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer1
Dong M. Shin; Nicholas J. Donato; Roman Perez-Soler; Hyung Ju C. Shin; Ji Y. Wu; Peter Zhang; Kristie Lawhorn; Fadlo R. Khuri; Bonnie S. Glisson; Jeffrey Myers; Gary Clayman; David Pfister; John Falcey; Harlan Waksal; John Mendelsohn; Waun Ki Hong
Phase I Trial of ISIS 5132, an Antisense Oligonucleotide Inhibitor of c-raf-1, Administered by 24-hour Weekly Infusion to Patients with Advanced Cancer1
Charles M. Rudin; Jon Holmlund; Gini F. Fleming; Sridhar Mani; Walter M. Stadler; Philip Schumm; Brett P. Monia; Joseph F. Johnston; Richard Geary; Rosie Z. Yu; T. Jesse Kwoh; F. Andrew Dorr; Mark J. Ratain
Phase I Pharmacokinetic Trial and Correlative in Vitro Phase II Tumor Kinetic Study of Apomine (SR-45023A), a Novel Oral Biphosphonate Anticancer Drug1
David S. Alberts; Alton V. Hallum III; Mary Stratton-Custis; Dava J. Garcia; Mary Gleason-Guzman; Sydney E. Salmon; Pedro Santabarbara; Eric J. Niesor; Simon Floret; Craig L. Bentzen
Molecular Oncology
Circulating Transforming Growth Factor β1 as a Predictor of Liver Metastasis after Resection in Colorectal Cancer
Hirofumi Tsushima; Nobuyuki Ito; Shinji Tamura; Yukihiko Matsuda; Masami Inada; Iwao Yabuuchi; Yasuharu Imai; Ryuichi Nagashima; Hiroyuki Misawa; Hiroaki Takeda; Yuji Matsuzawa; Sumio Kawata
Relation of Vascular Endothelial Growth Factor Production to Expression and Regulation of Hypoxia-inducible Factor-1α and Hypoxia-inducible Factor-2α in Human Bladder Tumors and Cell Lines1
Adam Jones; Chisato Fujiyama; Christine Blanche; John W. Moore; Sue Fuggle; David Cranston; Roy Bicknell; Adrian. L. Harris
Significant Correlation between Interleukin 10 Expression and Vascularization through Angiopoietin/TIE2 Networks in Non-small Cell Lung Cancer1
Hiroyuki Hatanaka; Yoshiyuki Abe; Masao Naruke; Tetsuji Tokunaga; Yoshiro Oshika; Tsutomu Kawakami; Hideo Osada; Junko Nagata; Jun-ichiro Kamochi; Takashi Tsuchida; Hiroshi Kijima; Hitoshi Yamazaki; Hiroshi Inoue; Yoshito Ueyama; Masato Nakamura
Coexpression of Inducible Nitric Oxide Synthase and COX-2 in Hepatocellular Carcinoma and Surrounding Liver: Possible Involvement of COX-2 in the Angiogenesis of Hepatitis C Virus-positive Cases
Md. Atiqur Rahman; Dipok Kumar Dhar; Emi Yamaguchi; Seiji Maruyama; Takashi Sato; Hikota Hayashi; Takashi Ono; Akira Yamanoi; Hitoshi Kohno; Naofumi Nagasue
Expression of MUC1 Mucins in the Subserosal Layer Correlates with Postsurgical Prognosis of Pathological Tumor Stage 2 Carcinoma of the Gallbladder1
Toru Kawamoto; Junichi Shoda; Tatsuro Irimura; Naoki Miyahara; Masato Furukawa; Tetsuya Ueda; Toru Asano; Masahito Kano; Naoto Koike; Katashi Fukao; Naomi Tanaka; Takeshi Todoroki
Experimental Therapeutics, Preclinical Pharmacology
Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents1
Kalkunte S. Srivenugopal; Jiang Shou; Srinivas R. S. Mullapudi; Frederick F. Lang, Jr.; Jasti S. Rao; Francis Ali-Osman
Effects of Dietary Curcumin on Glutathione S-Transferase and Malondialdehyde-DNA Adducts in Rat Liver and Colon Mucosa: Relationship with Drug Levels1
Ricky A. Sharma; Christopher R. Ireson; Richard D. Verschoyle; Kirsti A. Hill; Marion L. Williams; Chiara Leuratti; Margaret M. Manson; Lawrence J. Marnett; William P. Steward; Andreas Gescher
Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa),1 a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor2
Fortunato Ciardiello; Rosa Caputo; Roberto Bianco; Vincenzo Damiano; Gabriella Fontanini; Sabina Cuccato; Sabino De Placido; A. Raffaele Bianco; Giampaolo Tortora
Cancer Biology, Immunology, Cytokines
Letters to the Editor
Advertisement
